BRIACELL THERAP (BCTX)
(Delayed Data from NSDQ)
$0.68 USD
+0.05 (8.49%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.68 0.00 (-0.51%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, BRIACELL THERAP has a market cap of $4.27M, which represents its share price of $0.63 multiplied by its outstanding shares number of 6.78M. As a small-cap company, BCTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BCTX 0.68 +0.05(8.49%)
Will BCTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BCTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCTX
BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?
BCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock
Other News for BCTX
BriaCell Announces Proposed Effective Date of Share Consolidation | BCTX Stock News
BriaCell (BCTX) Expands Phase 3 Breast Cancer Study with UCLA Health
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study | BCTX Stock News
BriaCell adds UCLA Health as site in Phase 3 breast cancer study
BriaCell (BCTX) Secures New Zealand Patent for Innovative Cancer Vaccine